MTAP-deleted NSCLC research hub

A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)

This study is looking into a new drug called anvumetostat for people with a specific type of advanced lung cancer (NSCLC) that's missing a gene called MTAP. We want to see how safe the drug is and if it helps by slowing down or shrinking the cancer.